No headlines found.
No press releases found.
No news found.
Acruence aims to achieve XVOL s objectives by investing nearly all of the ETF s assets in a portfolio replicating the constituents and weights of the S&P 500 Index, while working to reduce volatility by purchasing options contracts on the CBOE Volatility Index, also known as the VIX. Historically, the VIX Index has shown a strong inverse relationship with the S&P 500 Index. The firm uses a proprietary, volatility-based algorithm to determine the number of VIX options contracts to purchase, as well as the strike price(s) and expiration date(s) of the options.
Acruence Active Hedge U.S. Equity ETF trades on the BATS stock market under the symbol XVOL.
As of December 19, 2025, XVOL stock price was flat at $23.32 with million shares trading.
XVOL has a market cap of $2.33 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, XVOL traded as high as $24.20 and as low as $16.52.
XVOL has underperformed the market in the last year with a price return of +8.4% while the SPY ETF gained +17.3%. XVOL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -0.1% and -1.0%, respectively, while the SPY returned +3.3% and -0.6%, respectively.
XVOL support price is $23.16 and resistance is $23.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XVOL shares will trade within this expected range on the day.